IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA ( BCR:ABL1 Mutation Analysis for TKI Resistance )

89 Ratings

Rs 17,820 Rs 13,500

24 % OFF

IMATINIB IS A TYROSINE KINASE INHIBITOR (TKI) CAPABLE OF INDUCING DURABLE HEMATOLOGIC AND CYTOLOGIC REMISSIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML). UNFORTUNATELY A SIGNIFICANT SUBSET OF PATIENTS DEVELOP FUNCTIONAL RESISTANCE TO TKI. RECOGNITION OF THIS RESISTANCE IS IMPORTANT IN CML AS THE EFFECT OF SOME MUTATIONS CAN BE OVERCOME BY IMATINIB DOSAGE.

Related Test/Package

-26%

Electrolytes, Serum

167 Ratings

Rs 500 Rs 675

-24%

Calcium, Serum (ca)

105 Ratings

IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA ( BCR:ABL1 Mutation Analysis for TKI Resistance )

Rs 17,820 Rs 13,500

24 % OFF

Why book with us?

Get a Free Call

IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA ( BCR:ABL1 Mutation Analysis for TKI Resistance )

Rs 17,820 Rs 13,500

24 % OFF

Why book with us?

Related Test/Package

Rs 500 Rs 675

Rs 130 Rs 176

Rs 540 Rs 724

Rs 800 Rs 1,064

Rs 360 Rs 468

Rs 200 Rs 264

Rs 500 Rs 650

Rs 50 Rs 66

Rs 700 Rs 945

Rs 7,500 Rs 10,050

Get a Free Call